Molecular Therapy - Oncolytics
Open Access
Journal formatting to fit the target journal guidelines
Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!
Key Metrics
View Chart Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
- PublisherCELL PRESS
- LanguageEnglish
- FrequencyContinuous publication
- Article Processing ChargesUSD 3900
- Publication Time6
- Editorial Review ProcessAnonymous peer review
- LanguageEnglish
- Society/Institute/SponsorAmerican Society for Gene and Cell Therapies
- FrequencyContinuous publication
- Publication Start Year2014
- Publisher URL
- Website URL
- Other charges
- Plagiarism
- Publication Time6
- Waiver Policy
- Editorial Team
- Review ProcessAnonymous peer review
- Review Url
- Author instructions
- License typeCC BY, CC BY-NC-ND
- OA statement
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Meets Top Publisher Standards: Essential for leading journals like Elsevier.Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
3000+ graphical abstracts produced with 4.8/5 customer rating | Months | % Papers published |
|---|---|
| 0-3 | 3% |
| 4-6 | 57% |
| 7-9 | 30% |
| >9 | 10% |
Topics Covered
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has Molecular Therapy - Oncolytics been publishing? 
The Molecular Therapy - Oncolytics has been publishing since 2014 till date.
How frequently is the Molecular Therapy - Oncolytics published?
Molecular Therapy - Oncolytics is published Continuous publication.
Who is the publisher of Molecular Therapy - Oncolytics?
The publisher of Molecular Therapy - Oncolytics is CELL PRESS.
How can I view the journal metrics of Molecular Therapy - Oncolytics on editage?
For the Molecular Therapy - Oncolytics metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Molecular Therapy - Oncolytics?
The eISSN number is 2372-7705 and pISSN number is 2372-7705 for Molecular Therapy - Oncolytics.
What is the focus of this journal?
The journal covers a wide range of topics inlcuding Virus, Breast cancer, Immunotherapy, Human cancer, Osteosarcoma, Hepatocellular carcinoma, Overall survival, Tumor microenvironment, Neuroblastoma, Toxicity, Oncolytic adenovirus, Tumor growth, Metformin, Cisplatin, Vaccinia, Autophagy, Epidermal growth factor receptor, Antigen, Chemotherapy resistance, Meningioma.
Why is it important to find the right journal for my research?
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career?
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only?
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.